Bank7 Corp. BSVN
55.85
0.56
1.01%
as of 25 Sep
- Market cap
- $526.7M
- P/E
- 12.6×
Follow BSVN
Growth Flags
show if company had growth for consecutive years
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
11.05 | 8.43 | 8.97 | 10.02 |
+8 more quarters Free account |
P/S ratio |
3.37 | 2.69 | 2.82 | 3.18 | |
P/FCF ratio |
9.47 | 7.99 | 9.35 | 9.66 | |
P/Operating CF |
62.18 | 22.73 | 42.72 | 26.30 | |
P/B ratio |
1.75 | 1.46 | 1.54 | 1.81 | |
Price to Tangible BV |
1.83 | 1.53 | 1.62 | 1.90 | |
EV/Sales |
1.78 | 0.92 | 0.98 | 1.33 | |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Operating CF |
4.93 | 2.51 | 2.90 | 3.64 | |
EV/FCF |
5.00 | 2.75 | 3.24 | 4.03 | |
Quick Ratio |
0.13 | 0.15 | 0.15 | 0.16 | |
Current Ratio |
1.11 | 1.10 | 1.09 | 1.09 | |
Net Debt/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.07 | 0.08 | 0.07 | 0.08 | |
Operating CF/Net income |
0.90 | 1.39 | 0.84 | 1.53 | |
Capex/Depreciation |
9.58 | (7.50) | (3.25) | (0.64) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
37.25% | 28.92% | 28.70% | 30.76% | |
Intangible Assets out of Total Assets |
0.01 | 0.01 | 0.01 | 0.01 | |
Share Based Compensation of Revenue |
1.86% | 1.84% | 2.33% | 2.34% | |
Graham Net Nets |
0.38 | 0.45 | 0.42 | 0.35 | |
Graham Number |
52.81 | 53.98 | 52.28 | 51.56 | |
Earnings Yield |
9.05% | 11.86% | 11.15% | 9.98% | |
Free Cash Flow Yield |
10.56% | 12.52% | 10.70% | 10.35% | |
Revenue per Share |
3.35 | 3.77 | 3.67 | 3.80 | |
Operating CF per Share |
0.79 | 1.75 | 0.96 | 1.76 | |
Capex per Share |
0.33 | (0.26) | (0.11) | (0.02) | |
Free Cash Flow per Share |
1.12 | 1.49 | 0.84 | 1.74 | |
Cash per Share |
23.33 | 26.39 | 27.01 | 27.16 | |
Shareholders Equity per Share |
27.98 | 27.38 | 26.58 | 25.58 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
27.98 | 27.38 | 26.58 | 25.58 | |
Free Cash Flow |
10.63 | 14.18 | 7.98 | 16.42 | |
Working Capital |
175.71 | 170.48 | 161.97 | 152.66 | |
Capital Expenditures |
3.13 | (2.47) | (1.08) | (0.21) | |
Net Current Asset Value |
175.71 | 170.48 | 161.97 | 152.66 | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
(0.10) | 0.07 | 0.03 | 0.01 | |
Net Profit Margin |
26.14% | 33.58% | 31.12% | 30.18% | |
Price to Operating Income |
8.44 | 6.43 | 6.82 | 7.63 | |
| Other line items | |||||
Average Payables |
1,615.97 | 1,611.34 | 1,608.15 | 1,580.52 | |
Average Assets |
1,875.34 | 1,865.28 | 1,851.72 | 1,815.94 | |
Average Common Equity |
249.08 | 240.74 | 232.10 | 222.95 |
Columns are period end dates